Usana Health Sciences Stock Revenue
| USNA Stock | USD 38.50 0.34 0.89% |
USANA Health Sciences fundamentals help investors to digest information that contributes to USANA Health's financial success or failures. It also enables traders to predict the movement of USANA Stock. The fundamental analysis module provides a way to measure USANA Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to USANA Health stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 921 M | 585.9 M |
USANA | Revenue |
USANA Health Sciences Company Revenue Analysis
USANA Health's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current USANA Health Revenue | 921.01 M |
Most of USANA Health's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, USANA Health Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of USANA
Projected quarterly revenue analysis of USANA Health Sciences provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of USANA Health match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in USANA Health's stock price.
USANA Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for USANA Health is extremely important. It helps to project a fair market value of USANA Stock properly, considering its historical fundamentals such as Revenue. Since USANA Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of USANA Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of USANA Health's interrelated accounts and indicators.
| 0.83 | 0.84 | -0.53 | 0.77 | 0.4 | ||
| 0.83 | 0.99 | -0.58 | 0.77 | 0.44 | ||
| 0.84 | 0.99 | -0.58 | 0.75 | 0.35 | ||
| -0.53 | -0.58 | -0.58 | -0.82 | -0.25 | ||
| 0.77 | 0.77 | 0.75 | -0.82 | 0.48 | ||
| 0.4 | 0.44 | 0.35 | -0.25 | 0.48 |
Click cells to compare fundamentals
USANA Revenue Historical Pattern
Today, most investors in USANA Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various USANA Health's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of USANA Health revenue as a starting point in their analysis.
USANA Health Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
USANA Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, USANA Health Sciences reported 921.01 M of revenue. This is 93.8% lower than that of the Personal Care Products sector and 88.93% lower than that of the Consumer Staples industry. The revenue for all United States stocks is 90.24% higher than that of the company.
USANA Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses USANA Health's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of USANA Health could also be used in its relative valuation, which is a method of valuing USANA Health by comparing valuation metrics of similar companies.USANA Health is currently under evaluation in revenue category among its peers.
USANA Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, USANA Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to USANA Health's managers, analysts, and investors.Environmental | Governance | Social |
USANA Health Institutional Holders
Institutional Holdings refers to the ownership stake in USANA Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of USANA Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing USANA Health's value.| Shares | Ubs Group Ag | 2024-09-30 | 184.8 K | Charles Schwab Investment Management Inc | 2024-09-30 | 179 K | Assenagon Asset Management Sa | 2024-09-30 | 124 K | Northern Trust Corp | 2024-09-30 | 116.7 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 110.5 K | Citadel Advisors Llc | 2024-09-30 | 107.8 K | Amvescap Plc. | 2024-09-30 | 95.5 K | Ameriprise Financial Inc | 2024-09-30 | 93.6 K | Bank Of New York Mellon Corp | 2024-09-30 | 89.1 K | Blackrock Inc | 2024-06-30 | 1.8 M | Vanguard Group Inc | 2024-09-30 | 1.6 M |
USANA Fundamentals
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0809 | ||||
| Profit Margin | 0.06 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 400.3 M | ||||
| Shares Outstanding | 19.06 M | ||||
| Shares Owned By Insiders | 41.70 % | ||||
| Shares Owned By Institutions | 57.71 % | ||||
| Number Of Shares Shorted | 491.96 K | ||||
| Price To Earning | 8.70 X | ||||
| Price To Book | 1.36 X | ||||
| Price To Sales | 0.85 X | ||||
| Revenue | 921.01 M | ||||
| Gross Profit | 804.71 M | ||||
| EBITDA | 123.11 M | ||||
| Net Income | 63.79 M | ||||
| Cash And Equivalents | 246.88 M | ||||
| Cash Per Share | 12.82 X | ||||
| Total Debt | 13.21 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 2.71 X | ||||
| Book Value Per Share | 27.98 X | ||||
| Cash Flow From Operations | 70.64 M | ||||
| Short Ratio | 5.95 X | ||||
| Earnings Per Share | 2.83 X | ||||
| Price To Earnings To Growth | 1.16 X | ||||
| Target Price | 46.5 | ||||
| Number Of Employees | 1.8 K | ||||
| Beta | 0.89 | ||||
| Market Capitalization | 733.79 M | ||||
| Total Asset | 632.76 M | ||||
| Retained Earnings | 445.22 M | ||||
| Working Capital | 298.9 M | ||||
| Current Asset | 244.26 M | ||||
| Current Liabilities | 131.41 M | ||||
| Net Asset | 632.76 M |
About USANA Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze USANA Health Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of USANA Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of USANA Health Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:Check out USANA Health Piotroski F Score and USANA Health Altman Z Score analysis. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.83 | Revenue Per Share 45.085 | Quarterly Revenue Growth (0.06) | Return On Assets 0.0809 |
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.